PharmaCyte Biotech, Inc.

13D and 13G Filings

13D/G filings
13D on 1 security, 13G on 1 security
Location
Las Vegas, NV
CIK
0001157075
Alternate names
NUVILEX, INC.
Form D filings
4 filings
All SEC filings
View on sec.gov
Issuer % of Class Filed
Schedule 13D · 1 security · may seek to influence control
Q/C Technologies, Inc. 13D/A
QCLS · 62856X300
74.0% 11/18/2025
Event 11/14/2025
Schedule 13G · 1 security · passive
Femasys Inc. 13G
FEMY · 31447E105
7.9% 3/18/2026
Event 3/17/2026

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.